Korábbi változatok

...

Those providing data for these tables should consider, "What do you want those who seek to implement 'living guidance' to know about 'data-to-evidence' strategies, initiatives and tools to make their efforts more successful? Likewise, "What do you want to know about efforts of others working in the knowledge ecosystem to make your data-to-knowledge efforts more successful?"

Notes from 10/22/20 Kick-off Call for Community

• Maria: some organizations (e.g., Norway initiative) looking at clinical data directly and consider its implications for providing guidance - e.g., augmenting clinical trial results to inform guidance on the topic. We should think about how this fits into the other work we're doing. MedMorph - looking at how to use FHIR to send data to endpoints like public health, registries, research to generate evidence, etc. Maria addressing focusing on processing data across organizations - e.g., as they're doing in Norway and medical societies (e.g., ACS - to determine if a guideline should be updated).
• JO: standards/value sets are a key infrastructure for this part of the cycle - and for making this part of the cycle work smoothly and in concert with the rest of the cycle. 
• Brian walked through slides 5 and 6 in this deck - re: standards about things like patient groups to support flow around the cycle.

Notes from 10/16-19/20 email exchange

From JO:

...

Piggybacking onto Matt’s comments, the alignment on semantics is in fact the principal goal of the COVID-19 Interoperability Alliance (https://covid19ia.org). In collaboration with various community stakeholders, we’ve authored more than 600 value sets and have made them freely available from both the Alliance website (no registration required, just download away) and VSAC (registration for a free account is required by NLM). If there are specific inquiries or even requests for value sets, I’d be happy to discuss. It’s our way of giving back to the community and making an impact on the pandemic.

...